Triamcinolone Acetonide in Patients With Serous Pigment Epithelial Detachment

NACompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

July 1, 2020

Study Completion Date

December 31, 2020

Conditions
Age-Related Macular Degeneration
Interventions
PROCEDURE

Subtenon injection of 40 mg triamcinolone acetonide

Subtenon injection of 40 mg triamcinolone acetonide: 1 initial injection of 40 mg triamcinolone acetonide, further injections will be base at month 3 examination.

PROCEDURE

Intravitreal injection of 4 mg triamcinolone acetonide

Intravitreal injection of 4 mg triamcinolone acetonide: 1 initial injection of 4 mg triamcinolone acetonide, further injections will be base at month 3 examination.

DIAGNOSTIC_TEST

Visometry

Ophthalmic examination

DIAGNOSTIC_TEST

Fluorescent angiography

Ophthalmic examination

DIAGNOSTIC_TEST

Refractometry

Ophthalmic examination

DIAGNOSTIC_TEST

Slit lamp examination

Ophthalmic examination

DIAGNOSTIC_TEST

Ophthalmoscopy

Ophthalmic examination

DIAGNOSTIC_TEST

OKT

Ophthalmic examination

DIAGNOSTIC_TEST

IOP

Ophthalmic examination

Trial Locations (4)

54000

Mykolaiv Region Ophthalmogical Hospital, Mykolaiv

65061

Odessa National Medical University, Odesa

The Filatov Institute of Eye Diseases and Tissue Therapy, Odesa

Unknown

CPUkraine, Kyiv

All Listed Sponsors
collaborator

Odessa National Medical University

OTHER

collaborator

Mykolaiv Region Ophthalmogical Hospital

OTHER

collaborator

Central Polyclinic of Internal Affairs of Ukraine

OTHER_GOV

lead

The Filatov Institute of Eye Diseases and Tissue Therapy

OTHER

NCT04292756 - Triamcinolone Acetonide in Patients With Serous Pigment Epithelial Detachment | Biotech Hunter | Biotech Hunter